Sawai Group Holdings Co., Ltd.

TSE:4887 Stock Report

Market Cap: JP¥212.8b

Sawai Group Holdings (4887) Stock Overview

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. More details

4887 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends3/6

4887 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Sawai Group Holdings Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sawai Group Holdings
Historical stock prices
Current Share PriceJP¥1,843.00
52 Week HighJP¥2,308.67
52 Week LowJP¥1,650.00
Beta-0.025
1 Month Change3.54%
3 Month Change-1.05%
1 Year Change-17.47%
3 Year Change26.96%
5 Year Change4.72%
Change since IPO254.42%

Recent News & Updates

Sawai Group Holdings' (TSE:4887) Conservative Accounting Might Explain Soft Earnings

Jul 01
Sawai Group Holdings' (TSE:4887) Conservative Accounting Might Explain Soft Earnings

Recent updates

Sawai Group Holdings' (TSE:4887) Conservative Accounting Might Explain Soft Earnings

Jul 01
Sawai Group Holdings' (TSE:4887) Conservative Accounting Might Explain Soft Earnings

We Think Sawai Group Holdings (TSE:4887) Can Stay On Top Of Its Debt

May 13
We Think Sawai Group Holdings (TSE:4887) Can Stay On Top Of Its Debt

Investors Still Waiting For A Pull Back In Sawai Group Holdings Co., Ltd. (TSE:4887)

Mar 07
Investors Still Waiting For A Pull Back In Sawai Group Holdings Co., Ltd. (TSE:4887)

Here's Why Sawai Group Holdings (TSE:4887) Has Caught The Eye Of Investors

Dec 20
Here's Why Sawai Group Holdings (TSE:4887) Has Caught The Eye Of Investors

Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden

Nov 30
Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden

Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

Sep 04
Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

Sawai Group Holdings Co., Ltd. (TSE:4887) Shares Could Be 47% Below Their Intrinsic Value Estimate

Aug 12
Sawai Group Holdings Co., Ltd. (TSE:4887) Shares Could Be 47% Below Their Intrinsic Value Estimate

Sawai Group Holdings (TSE:4887) Has A Pretty Healthy Balance Sheet

Jul 27
Sawai Group Holdings (TSE:4887) Has A Pretty Healthy Balance Sheet

Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

May 28
Is Now The Time To Put Sawai Group Holdings (TSE:4887) On Your Watchlist?

Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?

Apr 22
Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?

Is Sawai Group Holdings (TSE:4887) A Risky Investment?

Mar 06
Is Sawai Group Holdings (TSE:4887) A Risky Investment?

Shareholder Returns

4887JP PharmaceuticalsJP Market
7D1.7%-2.0%0.1%
1Y-17.5%-12.6%-2.1%

Return vs Industry: 4887 underperformed the JP Pharmaceuticals industry which returned -12.6% over the past year.

Return vs Market: 4887 underperformed the JP Market which returned -2.1% over the past year.

Price Volatility

Is 4887's price volatile compared to industry and market?
4887 volatility
4887 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement4.0%
10% most volatile stocks in JP Market7.8%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4887 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 4887's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19293,310Mitsuo Sawaiwww.sawaigroup.holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations. It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States.

Sawai Group Holdings Co., Ltd. Fundamentals Summary

How do Sawai Group Holdings's earnings and revenue compare to its market cap?
4887 fundamental statistics
Market capJP¥212.78b
Earnings (TTM)JP¥2.17b
Revenue (TTM)JP¥189.02b
97.9x
P/E Ratio
1.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4887 income statement (TTM)
RevenueJP¥189.02b
Cost of RevenueJP¥132.67b
Gross ProfitJP¥56.35b
Other ExpensesJP¥54.18b
EarningsJP¥2.17b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 12, 2025

Earnings per share (EPS)18.82
Gross Margin29.81%
Net Profit Margin1.15%
Debt/Equity Ratio52.5%

How did 4887 perform over the long term?

See historical performance and comparison

Dividends

3.0%
Current Dividend Yield
302%
Payout Ratio

Does 4887 pay a reliable dividends?

See 4887 dividend history and benchmarks
When do you need to buy 4887 by to receive an upcoming dividend?
Sawai Group Holdings dividend dates
Ex Dividend DateSep 29 2025
Dividend Pay DateDec 02 2025
Days until Ex dividend80 days
Days until Dividend pay date144 days

Does 4887 pay a reliable dividends?

See 4887 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/10 16:38
End of Day Share Price 2025/07/10 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sawai Group Holdings Co., Ltd. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Inc